Several microbial cultures were screened for the ability to catalyse t
he reduction of N-(4-(1-oxo-2-chloroacetyl ethyl) phenyl methane sulfo
namide (1). The chiral intermediate (+)N-(4-(1-hydroxy-2-chloroethyl)
phenyl methane sulfonamide (2) was prepared by the stereoselective mic
robial reduction of the parent ketone 1. Compound 2 is a potential chi
ral intermediate for synthesis of 4-(2-isopropylamino-1-hydroxyethyl)
phenyl methanesulfonanilide (D-sotalol), a beta-receptor antagonist. M
icroorganisms from the genera Rhodococcus, Nocardia, and Hansenula red
uced 1 to 2. A reaction yield of >50% and optical purities of >90% wer
e obtained. The best strain (H. polymorpha ATCC 26012) effectively red
uced compound 1 to compound 2 in 95% reaction yield and 99% optical pu
rity. Compound 2 (8.2 g) was isolated from a 3-1 preparative batch in
68% overall yield. Isolated compound 2 had a specific rotation of +20
degrees (CH2Cl2, C-1), an optical purity of 99.5%, and a chemical puri
ty of 97% as analyzed by gas chromatography and HPLC. The nuclear magn
etic resonance and mass spectra of compound 2 prepared by bioreduction
and a standard chemical sample of 2 were virtually identical. Cell ex
tracts of H. polymorpha in the presence of glucose dehydrogenase, gluc
ose and nicotinamide adenine dinucleotide (NAD(+)) catalyzed the reduc
tion of 1 to 2 with 98% reaction yield and resulted in an optical puri
ty of 99.4%.